Literature DB >> 26151324

Liquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors.

Catherine B Meador1, Christine M Lovly2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26151324     DOI： 10.1038/nm.3899

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.

Authors:  Sandra Misale; Rona Yaeger; Sebastijan Hobor; Elisa Scala; Manickam Janakiraman; David Liska; Emanuele Valtorta; Roberta Schiavo; Michela Buscarino; Giulia Siravegna; Katia Bencardino; Andrea Cercek; Chin-Tung Chen; Silvio Veronese; Carlo Zanon; Andrea Sartore-Bianchi; Marcello Gambacorta; Margherita Gallicchio; Efsevia Vakiani; Valentina Boscaro; Enzo Medico; Martin Weiser; Salvatore Siena; Federica Di Nicolantonio; David Solit; Alberto Bardelli
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.

Authors:  Zofia Piotrowska; Matthew J Niederst; Chris A Karlovich; Heather A Wakelee; Joel W Neal; Mari Mino-Kenudson; Linnea Fulton; Aaron N Hata; Elizabeth L Lockerman; Anuj Kalsy; Subba Digumarthy; Alona Muzikansky; Mitch Raponi; Angel R Garcia; Hillary E Mulvey; Melissa K Parks; Richard H DiCecca; Dora Dias-Santagata; A John Iafrate; Alice T Shaw; Andrew R Allen; Jeffrey A Engelman; Lecia V Sequist
Journal:  Cancer Discov       Date:  2015-05-01       Impact factor: 39.397

Review 3.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

Review 4.  Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution.

Authors:  Sandra Misale; Federica Di Nicolantonio; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli
Journal:  Cancer Discov       Date:  2014-10-07       Impact factor: 39.397

5.  Intratumor heterogeneity: seeing the wood for the trees.

Authors:  Timothy A Yap; Marco Gerlinger; P Andrew Futreal; Lajos Pusztai; Charles Swanton
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

6.  Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.

Authors:  Lecia V Sequist; Belinda A Waltman; Dora Dias-Santagata; Subba Digumarthy; Alexa B Turke; Panos Fidias; Kristin Bergethon; Alice T Shaw; Scott Gettinger; Arjola K Cosper; Sara Akhavanfard; Rebecca S Heist; Jennifer Temel; James G Christensen; John C Wain; Thomas J Lynch; Kathy Vernovsky; Eugene J Mark; Michael Lanuti; A John Iafrate; Mari Mino-Kenudson; Jeffrey A Engelman
Journal:  Sci Transl Med       Date:  2011-03-23       Impact factor: 17.956

Review 7.  Therapeutic strategies utilized in the setting of acquired resistance to EGFR tyrosine kinase inhibitors.

Authors:  Helena A Yu; Gregory J Riely; Christine M Lovly
Journal:  Clin Cancer Res       Date:  2014-10-10       Impact factor: 12.531

8.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

9.  AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.

Authors:  Pasi A Jänne; James Chih-Hsin Yang; Dong-Wan Kim; David Planchard; Yuichiro Ohe; Suresh S Ramalingam; Myung-Ju Ahn; Sang-We Kim; Wu-Chou Su; Leora Horn; Daniel Haggstrom; Enriqueta Felip; Joo-Hang Kim; Paul Frewer; Mireille Cantarini; Kathryn H Brown; Paul A Dickinson; Serban Ghiorghiu; Malcolm Ranson
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

10.  AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.

Authors:  Darren A E Cross; Susan E Ashton; Serban Ghiorghiu; Cath Eberlein; Caroline A Nebhan; Paula J Spitzler; Jonathon P Orme; M Raymond V Finlay; Richard A Ward; Martine J Mellor; Gareth Hughes; Amar Rahi; Vivien N Jacobs; Monica Red Brewer; Eiki Ichihara; Jing Sun; Hailing Jin; Peter Ballard; Katherine Al-Kadhimi; Rachel Rowlinson; Teresa Klinowska; Graham H P Richmond; Mireille Cantarini; Dong-Wan Kim; Malcolm R Ranson; William Pao
Journal:  Cancer Discov       Date:  2014-06-03       Impact factor: 39.397
View more
  8 in total

Review 1.  Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

Authors:  Mark Roschewski; Louis M Staudt; Wyndham H Wilson
Journal:  Blood       Date:  2016-04-14       Impact factor: 22.113

Review 2.  Pathologists and liquid biopsies: to be or not to be?

Authors:  Paul Hofman; Helmut H Popper
Journal:  Virchows Arch       Date:  2016-08-23       Impact factor: 4.064

3.  Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.

Authors:  Maysa Abu-Khalaf; Chun Wang; Zhenchao Zhang; Rui Luo; Weelic Chong; Daniel P Silver; Frederick Fellin; Rebecca Jaslow; AnaMaria Lopez; Terrence Cescon; Wei Jiang; Ronald Myers; Qiang Wei; Bingshan Li; Massimo Cristofanilli; Hushan Yang
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

4.  Microfluidic enrichment for the single cell analysis of circulating tumor cells.

Authors:  Trifanny Yeo; Swee Jin Tan; Chew Leng Lim; Dawn Ping Xi Lau; Yong Wei Chua; Sai Sakktee Krisna; Gopal Iyer; Gek San Tan; Tony Kiat Hon Lim; Daniel S W Tan; Wan-Teck Lim; Chwee Teck Lim
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

Review 5.  Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.

Authors:  Peter Horak; Stefan Fröhling; Hanno Glimm
Journal:  ESMO Open       Date:  2016-11-18

Review 6.  Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.

Authors:  Mamello Sekhoacha; Keamogetswe Riet; Paballo Motloung; Lemohang Gumenku; Ayodeji Adegoke; Samson Mashele
Journal:  Molecules       Date:  2022-09-05       Impact factor: 4.927

7.  Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.

Authors:  Eun Kyong Goag; Jung Mo Lee; Kyung Soo Chung; Song Yee Kim; Ah Young Leem; Joo Han Song; Ji Ye Jung; Moo Suk Park; Yoon Soo Chang; Young Sam Kim; Joon Chang; Eun Young Kim
Journal:  J Cancer       Date:  2018-03-02       Impact factor: 4.207

8.  Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery.

Authors:  Gersina Rega-Kaun; Dorothea Ritzel; Christoph Kaun; Benjamin Ebenbauer; Barbara Thaler; Manfred Prager; Svitlana Demyanets; Johann Wojta; Philipp J Hohensinner
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.